Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-22-025180
Filing Date
2022-04-21
Accepted
2022-04-21 16:50:22
Documents
1
Period of Report
2021-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 3597
  Complete submission text file 0001209191-22-025180.txt   4995
Mailing Address LEV PHARMACEUTICALS INC 122 EAST 42ND STREET STE 206 NEW YORK NY 10022
Business Address
RICHMAN ERIC I (Reporting) CIK: 0001313876 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40237 | Film No.: 22842071

Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Issuer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations